Genomics England

Genomics England is a company owned by the UK Department of Health and Social Care, established in July 2013 to lead the 100,000 Genomes Project. This initiative aimed to sequence whole genomes from NHS patients with rare diseases and cancers, marking a significant advancement in genomic medicine. The company specializes in whole genome sequencing, providing genomic diagnoses and personalized treatment options. It supports the NHS Genomic Medicine Service by offering infrastructure, training, and systems to incorporate genomic medicine into standard healthcare practices. Genomics England also shares genomic data with over 3,000 researchers worldwide, promoting medical research and improving patient outcomes. The company emphasizes ethical practices and transparency in its genomic programs, ensuring responsible handling of genomic data. Through collaborations with NHS Genomic Medicine Centres and industry partners like Illumina, Genomics England plays a vital role in advancing genomic science and medicine in the UK.